**About the Editors**

#### **Giovanni N. Roviello**

Dr. Giovanni Roviello graduated with honors in chemistry from Federico II University (2002, Naples, Italy) and received his PhD in Biotechnology from the same university in 2006. He works as a senior researcher at the Institute of Biostructure and Bioimaging (IBB) of the Italian National Council for Research (CNR) in Naples, Italy. He was a visiting researcher in Germany (Institute of Molecular Biotechnology (IMB)- Jena 2003, Georg-August University of Goettingen 2005, FAU University–Erlangen 2018), the UK (University of Greenwich–Medway Campus in Chatham Maritime 2022), and Ireland (UCD, Dublin 2017) working in the field of biorganic chemistry. He has strong scientific and teaching connections with Yerevan State University (Armenia) with which he works on two funded research projects, AMU University of Poznan (Poland) for which he served as a lecturer for the nucleic acids course for Ph.D. students in 2021 and with Geomedi University of Tbilisi (Georgia) having been appointed the honorary professorship in medicinal chemistry for this university in 2012. He is currently a lecturer for the Georgian State University of Physical Education and Sport of Tbilisi (Georgia) helding a course on the 'Biotechnological Basis of the Physical Rehabilitation' and is the principal investigator for CNR for different international research activities including the EU-funded project NobiasFluors (ID 872331; 2020–2024), the Royal Society (UK)-funded project 'Design, synthesis and in vitro evaluation of TMPRSS2 inhibitor analogues as potential novel anti-COVID-19 drugs' (2022–2024), the project code 21T-1D057 funded by the Science Committee of the Republic of Armenia (2021–2024), and the MESRA (Armenia)-CNR-funded bilateral project 'Synthetic alpha-amino acids and peptide-based systems for anticancer strategies' (2023–2025) to cite only a few. He serves as an academic editor for different international scientific journals and is author of more than 100 scientific articles.

#### **Caterina Vicidomini**

Dr. Caterina Vicidomini Ph.D. is a researcher in the field of the pharmaceutical sciences applied to the research and development of new lead compounds for both pharmacological therapy and for diagnostic purposes. Dr. Vicidomini graduated in Pharmacy at the University of Salerno in 2002 and subsequently performed research activity in the frame of her Ph.D. internship at the Department of Pharmaceutical Sciences of the same university. During this period, she gained experience in organic synthesis, chromatography purification and characterization of new compounds of pharmaceutical interest. In July 2008 she completed a Postgraduate Master in Clinical Pharmacy (summa cum laude) at University of Salerno. Since 2011 she is working as permanent researcher at Institute of Biostructure and Bioimaging of Italian National Council for Research (IBB-CNR) in the screening of organic substances of natural and synthetic origin against different biological targets (e.g., neoplastic pathologies, taupathies) also by means of computational chemistry. Dr. Vicidomini is also working in the field of neuroscience and is involved in studies concerning the molecular diagnostics related to neurodegenerative diseases such as Parkinson's disease and others. Among the other skills of Dr. Vicidomini, the ability of coordinating the activities of research teams aimed at developing biologically active compounds is worth of mention together with the capability of working in highly multidisciplinary environments involving organic chemists, neurologists, radiologists, to cite only a few, collaborating with scientists having the most diverse backgrounds in order to set up and arrange strategies for the implementation of multidisciplinary projects.
